Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Financing Activities (2016 - 2018)

Historic Cash from Financing Activities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q4 2018 value amounting to $6.1 million.

  • Armata Pharmaceuticals' Cash from Financing Activities rose 305582.52% to $6.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $12.5 million, marking a year-over-year increase of 4359.36%. This contributed to the annual value of $35.0 million for FY2024, which is 3524.86% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' Cash from Financing Activities stood at $6.1 million, which was up 305582.52% from -$44000.0 recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Cash from Financing Activities high stood at $12.4 million for Q1 2015, and its period low was -$611000.0 during Q3 2017.
  • Moreover, its 4-year median value for Cash from Financing Activities was -$1000.0 (2015), whereas its average is $2.9 million.
  • In the last 5 years, Armata Pharmaceuticals' Cash from Financing Activities tumbled by 349411.76% in 2017 and then skyrocketed by 332439.02% in 2018.
  • Quarter analysis of 4 years shows Armata Pharmaceuticals' Cash from Financing Activities stood at -$1000.0 in 2015, then skyrocketed by 325600.0% to $3.3 million in 2016, then crashed by 106.33% to -$206000.0 in 2017, then surged by 3055.83% to $6.1 million in 2018.
  • Its last three reported values are $6.1 million in Q4 2018, -$44000.0 for Q3 2018, and -$204000.0 during Q2 2018.